EARNING RECAP

Apple Inc

#AAPL 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q2 $2.46 EST. $2.36 $58.01b EST. $57.37b +4.91% ($210.52 CLOSING PRICE) $215.31 $209.23 authorizes additional $75B fro share repurchases & raises quarterly dividend by 5% to 77c; ; says Q2 Services segment had its best quarter with $11.5B in revenue; sees Q3 revenue $52.5B-$54.5B est. $51.93B
Q1 $4.18 est. $4.17 $84.3B est. $84B +6.83% ($165.24 closing price) $166.15 $160.23 sees Q2 revenue $55B- $59B est. $58.99B; Q1 iPhone revenue down 15% YoY while total revenue from all other services up 19%
#AAPL 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $2.91 est. $2.78 $62.9B est. $61.57B -6.63% ($207.48 closing) $213.65 $205.43 reports Q4 iPhone units 46.89M vs. 46.68M last year; says will no longer report iPhone, iPad, Mac unit sales
Q3 $2.34 est. $2.18 $53.3B est. $52.34B +5.89% ($201.50 closing) $201.76 $197.31 Q3 iPhone revenue $29.91B vs. $24.85B last year; says on track to double 2016 revenues by 2021; stock price trades at record high
Q2 $2.73 Vs $2.69 $61.1B Vs $60.98B +4.42% ($176.57 closing) $177.75 $173.80 $100B buyback, boosts dividend by 16%. iPhone Units 52.22m
Q1 Q1 EPS $3.89 est. $3.86 $88.3B est. $87.28B. -4.42% ($160.37 closing) $166.80 $160.10 active installed base of devices reaching 1.3 billion in January
#AAPL 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $2.07 vs $1.87 est $52.6B Vs $50.79B +2.61% ($172.50 closing) $174.26 $171.12 Shipments: 46.7M iPhones, 10.3M iPads, 5.4M Macs.
Q3 $1.67 vs $1.57 $45.4B vs $44.89B +4.73% ($157.14 closing) $159.75 $156.16 iPhone units 41.03M vs $50.76M last Q. stock +4.29% to 156.63.
Q2 $2.10 vs $2.02 est Q2 revenue $52.9B, consensus $52.97B. -0.31% ($147.06) $147.49 $144.27 sees Q3 revenue $43.5B-$45.5B, consensus $45.57B. iPhone sales 50.8 vs 51.40 est. Cash $256.8B up $10.75B last qtr

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.